Prostate Cancer: Fusion Biopsy

ABC 30 action news logo
/ Uncategorized

published on KFSN: An ABC Affiliate

NEW YORK. (KFSN) – For decades, doctors have diagnosed prostate cancer using what’s been called a ‘blind’ biopsy, removing and testing a dozen tiny tissue samples to see if cancer is present. Now, new technology is taking the guesswork out of the procedure by allowing doctors to precisely target suspicious areas where deadly cells may be lurking.

High-tech images and an electromagnetic tracking system, like GPS for the body, work together, giving doctors more information than ever before.

Arcenio Miller has prostate cancer. But he feels good knowing that doctors have a very clear picture of his condition. Miller told Ivanhoe, “More lesions came out and more spots were detected.”

Doctors found cancer in an area of Miller’s prostate that would not have been targeted by a traditional biopsy, using a system called UroNav.

UroNav fuses together a patient’s MRI and ultrasound to create a highly-detailed 3D view of the prostate.

Art Rastinehad, D.O., Director of Focal Therapy and Interventional Urologic Oncology and Associate Professor of Urology and Radiology at Icahn School of Medicine at Mount Sinai said, “We’re able to guide the needles in the treatment area and just focus on that specific spot.”

 

Click here to read the full article on KFSN: An ABC Affiliate

DAR_logofull_white (1)-nopadding

Dr. Rastinehad is board certified by the American Board of Urology. He has expertise in an array of interventional radiological and surgical techniques.

Dr. Art Rastinehad © 2019 | Website by CURE